New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the Antarctic desert soil.
Since the recent pandemic, our use of disinfectants has surged, but could our push for sterile urban environments be backfiring?
A new study published in the journal Microbiome has identified novel strains of microbes that have adapted to use the limited resources available in cities and shown that our everyday behavior is changing the makeup of microorganisms in indoor environments.
“Built environments offer distinct conditions that set them apart from natural and engineered habitats,” says Dr. Xinzhao Tong, an assistant professor at Xi’an Jiaotong-Liverpool University (XJTLU), China, and lead author of the study.
“Areas with many buildings are low in the traditional nutrients and essential resources microbes need for survival, so these built environments have a unique microbiome.
“Our use of cleaning and other manufactured products creates a unique setting that puts selective pressures on microbes, which they must adapt to or be eliminated, but the mechanisms by which microbes adapt and survive in built environments are poorly understood,” Dr. Tong explains.
City dwellers
The researchers collected 738 samples from a variety of built environments, including subways, residences, public facilities, piers, and human skin in Hong Kong. They then used shotgun metagenomic sequencing to analyze the microbes’ genomic content and understand how they have adapted to the challenging urban conditions.
The team identified 363 microbial strains that have not been previously identified that live on our skin and the environment around us. Some of these strains’ genomes contained genes for metabolizing manufactured products found in cities and using them as carbon and energy sources. This includes the discovery of a strain of Candidatus phylum Eremiobacterota, previously only reported in Antarctic desert soil.
Specialized metabolic capacities of microbes in oligotrophic built environments. Tong et al. “Diverse and specialized metabolic capabilities of microbes in oligotrophic built environments.” Microbiome (2024). Credit: AJE Video Bytes, in partnership with Springer Nature Group
Dr Tong says: “The genome of this novel strain of Eremiobacterota enables it to metabolize ammonium ions found in cleaning products. The strain also has genes for alcohol and aldehyde dehydrogenases to break down residual alcohol found in common disinfectants.
“Microbes possessing enhanced capabilities to utilize limited resources and tolerate manufactured products, such as disinfectants and metals, out-compete non-resistant strains, enhancing their survival and even evolution within built environments. They could, therefore, pose health risks if they are pathogenic.”
The team identified 11 unique, previously uncharacterized strains of Micrococcus luteus, typically non-pathogenic but capable of causing opportunistic infections in immunocompromised individuals.
“The issue of their adaptation to our behavior becomes particularly critical in clinical settings where hospitals serve as hotspots for diverse pathogens that cause hospital-acquired infections (HAIs). HAIs pose a significant threat, particularly in intensive care units where mortality rates can reach up to 30%,” says Dr Tong.
A balancing act
The researchers also characterized two novel strains of Patescibacteria, known as “nanobacteria”, as they have tiny genomes that do not contain many genes for producing their own resources.
Dr Tong says: “Some strains of Patescibacteria are considered parasitic as they rely on bacterial hosts to supply their nutrients. However, in this study, the researchers found that one of the nanobacteria strains, recovered from human skin, contains genes for the biosynthesis of carotenoids and ubiquinone. These antioxidant compounds are vital to humans, and we typically acquire them, especially carotenoids, through our diets, suggesting a possible mutualistic relationship between bacteria and us as their hosts.”
This enhanced understanding of microbial metabolic functions within built environments helps develop strategies to create a healthy indoor ecosystem of microbes for us to live alongside.
The team is now investigating the transmission and evolution of resistance in pathogenic microbes in intensive care units that are exposed to stringent and extensive disinfectant practices. They hope to improve infection control practices and increase the safety of clinical environments for healthcare workers and patients.
Reference: “Diverse and specialized metabolic capabilities of microbes in oligotrophic built environments” by Xinzhao Tong, Danli Luo, Marcus H. Y. Leung, Justin Y. Y. Lee, Zhiyong Shen, Wengyao Jiang, Christopher E. Mason and Patrick K. H. Lee, 17 October 2024, Microbiome.
DOI: 10.1186/s40168-024-01926-6
Funding: Hong Kong Research Grants Council Research Impact 642 Fund, Natural Science Foundation of Jiangsu Province, Hong Kong Research Grants Council General Research Fund
News
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
